Management of blood pressure in acute neurologic illnesses

Neurologist

Volumn 2, Issue 4, 1996, Pages 196-206

  Teitelbaum, Jeanne S ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

Antihypertensive agents; Blood pressure; Cerebral aneurysms; Cerebral hemorrhage; Cerebrovascular disorders; Hypertension; Intracranial hypertension

Indexed keywords

EID: 0009538628     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (111)

1. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-74.
2. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: Overview of randomized drug trials in their epidemiological context. Lancet 1990;335:827-38.
3. Mohr JP, Caplan LR, Melski JW, Goldstein RJ, Duncan JW, Kistler JP, et al. The Harvard Cooperative Stroke Registry. Neurology 1978;28:754-62.
4. Bonita R. Cigarette smoking, hypertension and the risk of subarachnoid hemorrhage: A population based case-control study. Stroke 1986;17:831-5.
5. Kety SS, Hafkenschiel JH, Jeffers WA. The blood flow, vascular resistance and oxygen consumption of the brain in essential hypertension. J Clin Invest 1948;27:511.
6. McDowell DG. Drugs and cerebral autoregulation. Eur J Clin Invest 1982;12:377-8.
7. Strandgaard S, Oleson J, Skinhoj E, Lassen NA. Autoregulation of brain circulation in severe arterial hypertension. BMJ 1973;1:507-10.
8. Daugherty SA, Berman R, Entwisle G, Haerer AF. Cerebrovascular events in the hypertension, detection and follow-up program. Prog Cardiovasc Dis 1986;29:63-72.
9. Wallace JD, Levy LL. Blood pressure after stroke. JAMA 1981;246: 2177-80.
10. Britton M, Carlsson A, De Faire U. Blood pressure course in patients with acute stroke and matched controls. Stroke 1986;17:861-4.
11. Harper G, Castleden CM, Potter JF. Factors affecting blood pressure after acute stroke. Stroke 1994;25:1726-9.
12. Coope J, Warrender TS, McPherson K. Pronostic significance of blood pressure in the elderly. J Hum Hypertens 1988;2:79-88.
13. Powers WJ. Hemodynamics and metabolism in ischemic cerebrovascular disease. Neurol Clin 1992;10:31-8.
14. Fieschi C, Agnoli A, Battistini N, Bozzao L, Prencipe M. Derangement of regional cerebral blood flow and of its regulatory mechanisms in acute Cerebrovascular lesions. Neurology 1968;18:1166-79.
15. Meyer JS, Shimazu K, Fukuuchi Y, Ouchi T, Okamoto S, Koto A. Impaired neurogenic Cerebrovascular control and dysautoregulation after stroke. Stroke 1973;4:169-86.
16. Paulson OB. Regional cerebral blood flow in apoplexy due to occlusion of middle cerebral artery. Neurology 1970;20:63-7.
17. Symon L, Pasztor E, Branston NJM. The distribution and density of reduced cerebral blood flow following acute middle cerebral artery occlusion: An experimental study by the technique of hydrogen clearance in baboons. Stroke 1974;5:355-64.
18. Meyer JS. Circulatory changes following occlusion of the middle cerebral artery and their relation to function. J Neurosurg 1958;15: 653-73.
19. Waltz AG. Effect of blood pressure on blood flow in ischemic and nonischemic cerebral cortex: The phenomena of autoregulation and luxury perfusion. Neurology 1968;18:613-21.
20. Astrup J, Siesjo B, Symon L. Thresholds in cerebral ischemia: The ischemic penumbra. Stroke 1981;12:723-5.
21. Britton M, Carlsson A. Very high blood pressure in acute stroke. J Intern Med 1990;228:611-5.
22. Tuhrim S, Dambrosia JM, Price TR, Mohr JP, Wolf PA, Hayman A, et al. Prediction of intracerebral hemorrhage survival. Ann Neurol 1988;24:258-63.
23. Marshall J. Cerebral hemorrhage. In: The management of cerebrovascular disease. 3rd ed. Oxford, UK: Blackwell Scientific Publications, 1976:87-99.
24. Wood DH. Managing the hypertensive patient with cerebrovascular disease. J Nad Med Assoc 1984;76:16-23.
25. Cruickshank JM, Higgins TJ, Pennert K, Thorp JM, Zacharias FM, Zacharias FJ. The efficacy and tolerability of antihypertensive treatment based on atenolol in the prevention of stroke and the regression of left ventricular hypertrophy. J Hum Hypertens 1987;1:87-93.
26. Graham DI. Ischaemic brain damage of cerebral perfusion pressure type after treatment of severe hypertension. BMJ 1975;4:739.
27. Britton M, De Faire U, Helmers C. Hazards of therapy for excessive hypertension in acute stroke. Acta Med Scand 1980;207:253-7.
28. Patel PM, Drummond JC, Cole DJ. Delayed institution of hypertension during focal ischemia: Effect on brain edema. Acta Neuropathol 1991;81:339-44.
29. Wise G, Sutter R, Burkholder J. The treatment of brain ischemia with vasopressor drug. Stroke 1972;3:135-40.
30. Fenske A, Kohl J, Regli F, Reuben HJ. The effect of arterial hypertension on focal ischemic edema. J Neurol 1978;219:241-51.
31. Sukriti NAG, Robertson DM, Dinschle HB. Cerebral cortical changes in acute experimental hypertension (an ultrastructural study). Lab Invest 1977;36:150-61.
32. Durward QJ, Del Maestro RF, Amacher AL, Farrar JK. The influence of systemic arterial pressure and intracranial pressure on the development of edema. J Neurosurg 1983;59:803-9.
33. Skinhoj E, Strandgaard S. Pathogenesis of hypertensive encephalopathy. Lancet 1973;1:461-2.
34. Bell BA, Symon L, Branston NM. Cerebral blood flow and time thresholds for the formation of ischemic cerebral edema, and effect of reperfusion in the baboon. J Neurosurg 1985;62:31-41.
35. Yamaguchi S, Kobayashi S, Yamashita K, Kitani M. Pial arterial pressure contribution to early ischemic brain edema. J Cereb Blood Flow Metab 1989;9:597-602.
36. Dahl T, Abildgaard U, Sandset PM. Longterm anticoagulant therapy in cerebrovascular disease: Does bleeding outweigh the benefit? J Intern Med 1995;237:323-9.
37. Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke 1995;26:1471-7.
38. Shields RW Jr, Laureno R, Lachman T, Victor M. Anticoagulant related hemorrhage in acute cerebral embolism. Stroke 1984;15: 426-37.
39. Okada Y, Yamaguchi T, Minematsu K, Miyashita T, Sawada T, Sadomisha S, et al. Hemorrhagic transformation in cerebral embolism. Stroke 1989;20:598-603.
40. Levy DE, Brott TG, Haley EC, Marler JR, Sheppard GL, Barsan W, et al. Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke 1994;25:291-7.
41. Fibrinolytic Therapists Trialists (FTT) Collaborative Study Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-22.
42. Cerebral Embolism Study Group. Cardiogenic brain embolism. Arch Neurol 1989;46:727-43.
43. Rothrock JF, Hart RG. Antithrombotic therapy in cerebrovascular disease. Ann Intern Med 1992;115:885-95.
44. National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:581-7.
45. Hatashita T, Ito M, Miyaoka M, Ishii S. Chronological alteration of regional cerebral blood flow, glucose utilization, and edema formation after focal ischemia in hypertensive and normotensive rats. Significance of hypertension. Adv Neurol 1990;52:29-37.
46. Hachinski V. Hypertension in acute ischemic strokes. Arch Neurol 1985;42:1002.
47. Spence JD, Del Maestro RF. Hypertension in acute ischemic strokes: treatment. Arch Neurol 1985;42:1000.
48. O'Connell JE, Gray CS. Treating hypertension after stroke. BMJ 1994;308:1523-4.
49. Yatsu FM, Zivin T. Hypertension in acute ischemic strokes. Not to treat. Arch Neurol 1985;42:999.
50. Caplan L. Intracerebral hemorrhage revisited. Neurology 1988;38: 624-7.
51. Yukihiko F, Tanaka R, Takeuchi S, Koike T, Minakawa T, Sasaki O. Hematoma enlargement in spontaneous cerebral hemorrhage. J Neurosurg 1994;80:51-7.
52. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Ultraearly evaluation of intra-cerebral hemorrhage. J Neurosurg 1990;72: 195-9.
53. Chen ST, Chen SD, Hsu CY, Hogan EL. Progression of hypertensive intra-cerebral hemorrhage. Neurology 1989;39:1509-14.
54. Passero S, Burgalassi L, D'Andrea P, Battistini N. Recurrence of bleeding in patients with primary intracerebral hemorrhage. Stroke 1995;26:1189-92.
55. Bullock R, Brock-Utne J, Van Dellen J, Blake G. Intracerebral hemorrhage in a primate model: Effect on regional cerebral blood flow. Surg Neurol 1988;29:101-7.
56. Kingman TA, Mendelow AD, Graham DI, Teasdale GM. Experimental intracerebral mass: Time-related effects on local cerebral blood flow. J Neurosurg 1987;67:732-8.
57. Kobari M, Gotoh F, Tomita M, Tanahashi N, Shinohara T, Terayama Y, et al. Bilateral hemispheric reduction of cerebral blood volume on blood flow immediately after experimental cerebral hemorrhage in cats. Stroke 1988;19:991-6.
58. Nath FP, Jenkins A, Mendelow AD, Graham DI, Teasdale GM. Early hemodynamic changes in experimental intracerebral hemorrhage. J Neurosurg 1986;65:697-703.
59. Kanako T, Sawada T, Nimii T, Kobayashi S. Lower limit of blood pressure in treatment of acute hypertensive intracranial hemorrhage. J Cereb Blood Flow Metab 1983;3:S51-2.
60. Ram CVS. Hypertension associated with intracerebral hemorrhage. Curr Prob Cardiol 1982;7:23-5.
61. Hier DB, Davis KR, Richardson EP Jr, Mohr JP. Hypertensive putaminal hemorrhage. Ann Neurol 1977;1:152-9.
62. Kelley RE, Berger JR, Scheinberg P, Stokes N. Active bleeding in hypertensive intracerebral hemorrhage: Computed tomography. Neurology 1982;32:852-6.
63. Dandapani BK, Susuki S, Kelley RE, Reyes-Iglesias Y, Duncan RC. Relation between blood pressure and outcome in intra-cerebral hemorrhage. Stroke 1995;26:21-4.
64. Langlitt TW. Increased intracranial pressure and the cerebral circulation. In: Youman JR, editor. Neurological surgery. 2nd ed. Vol 2. Philadelphia: Saunders, 1982:846-930.
65. Langlitt TW. Increased intracranial pressure. Clin Neurosurg 1969; 16:436-71.
66. Langlitt TW, Weinstein JD, Kassell NF. Cerebral vasomotor paralysis produced by intracranial hypertension. Neurology 1965;15:622-41.
67. Diringer M, Ladenson PW, Borel C, Hart GK, Kirsch JR, Hanley DF. Sodium and water regulation in patients with cerebral salt wasting. Arch Neurol 1989;46:928-30.
68. Hortnagl H, Hammerle AF, Hackl JM, Brucke T, Rumple E. The activity of the sympathetic nervous system following severe head injury. Intensive Care Med 1980;6:169-77.
69. Schulte EJ, Murday H, Pfeifer G. Hemodynamic changes in patients with severe head injury. Acta Neurochir (Wein) 1980;54:243-50.
70. Lewelt W, Jenkins LW, Miller JD. Autoregulation of cerebral blood flow after experimental fluid percussion injury of the brain. J Neurosurg 1989;53:500-11.
71. Obrist WD, Genarekki TA, Segawa H, Dolinskas CA, Langfitt TW. Relation of cerebral blood flow to neurological status and outcome in head-injured patients. J Neurosurg 1979;51:292-300.
72. Overgaard J, Tweed WA. Cerebral circulation after head injury wth emphasis on clinical correlations. J Neurosurg 1974;41:531-41.
73. Overgaard J, Mosdal C, Tweed WA. Cerebral circulation after head injury. Part 3. J Neurosurg 1981;55:63-74.
74. Rosner MJ, Daughton RN. Cerbral perfusion pressure management in head injury. J Trauma 1990;30:933-41.
75. Ropper AH. Mangement of severe head injury. In: Ropper AH, editor. Neurological and neurosurgical intensive care. 3rd ed. New York: Raven Press, 1993:203-43.
76. Locksley HB. Natural history of subarachnoid hemorrhage, intracranial aneurysms and arteriovenous malformations. In: Sahs AL, Perret GE, Locksley HB, editors. Intracranial aneurysms and subarachnoid hemorrhage. Philadelphia: JB Lippincott, 1969:37-57.
77. Carpenter DA, Grubb RL Jr, Tempell LW, Powers WJ. Cerebral oxygen metabolism after subarachnoid hemorrhage. J Cereb Blood Flow Metab 1991;11:837-44.
78. Weir B. Aneurysms affecting the nervous system. Baltimore: Williams & Wilkins 1987:262-307.
79. Heilbrun MP, Oleson J, Lassen NA. Regional cerebral blood flow studies in subarachnoid hemorrhage. J Neurosurg 1972;37:36-44.
80. Voldby B, Enevoldsen EM, Jensen FT. Cerebrovascular reactivity in patients with ruptured intracranial aneurysms. J Neurosurg 1985;62: 59-67.
81. Biller J, Godersky JC, Adams HP Jr. Management of aneurysmal subarachnoid hemorrhage. Stroke 1988;19:1300-5.
82. Nibbelink DW, Torner JC, Henderson WG. Randomized treatment study: Drug induced hypotension. In: Sahs AL, Nibbelink DW, Torner JC, editors. Aneurysmal subarachnoid hemorrhage. Baltimore: Urban and Schwartzenburg, 1981:77-106.
83. Awad IA, Carter LP, Spetzler RF, Medina M, Williams FC Jr. Clinical vasospasm after subarachnoid hemorrhage: Response to hypervolemic hemodilution and arterial hypertension. Stroke 1987;18: 365-72.
84. Dinsdale HB. Hypertensive encephalopathy. In: Barnett HJM, Mohr JP, Stein BM, Yatsu FM, editors. Stroke: Pathophysiology, diagnosis and management. New York: Churchill Livingstone, 1986:869-74.
85. Strandgaard S, Mackenzie ET, Sengupta D, Rowan JO, Lassen NA, Harper AM. Upper limit for autoregulation of cerebral blood flow in the baboon. Circ Res 1974;34:435-40.
86. Chester EM, Agmanolis DP, Banker BQ, Victor M. Hypertensive encephalopathy: A clinico-pathologic study of 20 cases. Neurology 1978;28:928-39.
87. Healton EB, Brust JC, Feinfeld DA, Thomson GE. Hypertensive encephalopathy and the neurologic manifestations of malignant hypertension. Neurology 1982;32:127-32.
88. Kinkaid-Smith P, McMichael J, Murphy ED. The clinical course and pathophysiology of hypertension with papilloedema. Q J Med 1958;105:117-53.
89. Phillips SJ, Whisnant JP. Hypertension and the brain. Arch Intern Med 1992;152:938-45.
90. Tietjen CS, Hum PD, Ulatowsky JA, Kirsch JR. Treatment modalities for hypertensive patients with intracranial pathology: Options and risks. Crit Care Med 1996;24:311-22.
91. Cottrell JE, Gupta B, Rappaport H, Turndorf H, Ransohoff J, Flamm ES. Intracranial hypertension during nitroglycerin induced hypotension. J Neurosurg 1980;53:309-11.
92. Cottrell JE, Patel K, Turndorf H, Ransohoff J. Intracranial pressure changes induced by sodium nitroprusside in patients with intracranial mass lesions. J Neurosurg 1978;48:329-31.
93. Waldemar G, Paulson OB. Angiotensin convening enzyme inhibition and cerebral circulation: A review. Br J Clin Pharmacol 1989; 28:177S-82S.
94. Puchstein C, Van-Aken H, Hidding J, Anger C, Lawin P. Treatment of hypertension with labetalol in neurosurgical practice. Influence of labetalol on cerebral perfusion pressure in dogs with and without intracranial mass lesions. Acta Neurochir (Wein) 1983;67: 283-90.
95. Feibel JH, Baldwin CA, Joynt RJ. Catecholamine-associated refractory hypertension following acute intracranial hemorrhage: Control with propranolol. Ann Neurol 1981;9:340-3.
96. Fagan SC, Robert S, Ewing JR, Levine SR, Ramadan NM, Welch KM. Cerebral blood flow changes with enalapril. Pharmacotherapy 1992;12:319-23.
97. Hayashi M, Kobayashi H, Kawano H, Handa Y, Hirose S. Treatment of systemic hypertension and intracranial hypertension in cases of brain hemorrhage. Stroke 1988;19:314-21.
98. Robert B, Petit JY, Grimaud N, Juge M, Welin L. Effect of clonidine on experimental brain edema in the rat. Agents Actions 1992; 37:268-72.
99. Jacewicz M, Brint S, Tanabe J, Wang XJ, Pulsinelli WA. Nimodipine pretreatment improves cerebral blood flow and reduces brain edema in conscious rats subjected to focal cerebral ischemia. J Cereb Blood Flow Metab 1990;10:903-13.
100. Bertel O, Conen LD. Treatment of hypertensive emergencies with the calcium channel blocker nifedipine. Am J Med 1985;79(Suppl 4A):31-5.
101. Halpern NA, Goldberg M, Neely C, Sladen RN, Goldberg JS, Floyd J, et al. Post-operative hypertension: A multicenter, prospective, randomized comparison between intravenous nicardipine and sodium nitroprusside. Crit Care Med 1992;20:1637-43.
102. Wallin JD. Intravenous nicardipine hydrochloride: Treatment of patients with severe hypertension. Am Heart J 1990;119:434-7.
103. Rosenbaum D, Zabramsi J, Frey J, Yatsu F, Marler J, Spetzler R, et al. Early treatment of stroke with a calcium antagonist. Stroke 1991; 22:437-41.
104. Adams HP Jr. Calcium antagonists in the management of patients with aneurysmal subarachnoid hemorrhage: A review. Angiology 1990;41:1010-6.
105. Compton JS, Lee T, Jones NR, Waddell G, Teddy PJ. A double blind placebo controlled trial of the calcium entry blocking drug, nicardipine, in the treatment of vasospasm following severe head injury. Br J Neurosurg 1990;4:9-15.
106. Griffin JP, Cottrell JE, Hartnung J, et al. Intracranial pressure during nifedipine induced hypotension. Anesth Analg 1985;64:1001-4.
107. Nishikawa T, Omote K, Nakimi A, et al. The effects of nicardipine on cerebrospinal fluid in humans. Anesth Analg 1986;65:507-10.
108. Bertel O, Conen LD, Radu EW, Muller J, Lang C, Dubach UC. Nifedipine in hypertensive emergencies. BMJ Clin Res Ed 1983; 286:19-21.
109. Miyamori I, Yasuhara S, Matsubata T, Takasaki H, Takeda R. Effects of a calcium entry blocker on cerebral circulation in essential hypertension. J Clin Hypertens 1987;3:528-35.
110. Gaab MR, Hollerhage HG, Walter GF, Hochender M, Haubitz I. Brain edema, autoregulation and calcium antagonism. An experimental study with nimodipine. Adv Neurol 1990;52:391-400.
111. Johansson B, Strandgaard S, Lassen NA. On the pathogenesis of hypertensive encephalopathy: The hypertensive "breakthrough" of autoregulation of cerebral blood flow with forced vasodilatation, flow increase, and blood brain barrier damage. Circ Res 1974;34(Suppl 1):167-74.